Company / Gross Profit per Share
Regenerative Medical Technology Group Inc. Gross Profit per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.22
FY2025
5-year range
$0.07 / $0.23
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.13 to $0.22 over the past 2 years.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of +176.1%.
Improved from $0.13 to $0.22 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +45.6%
- 5-Year CAGR
- +176.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share decreased 0.8% year-over-year.
- Peak gross profit per share was recorded in FY2024.
- Lowest gross profit per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | -0.8% |
| FY2024 | $0.23 | +67.8% |
| FY2023 | $0.13 | +85.6% |
| FY2022 | $0.07 | - |
| FY2021 | - | - |
| FY2020 | $0.00 | +127.0% |
| FY2019 | -$0.01 | -6.6% |
| FY2018 | -$0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026